Company profile
Journey Medical Corporation
NASDAQ: DERM · Healthcare · Drug Manufacturers - Specialty & Generic
#409 of 1,418 Healthcare companies by revenue57th-percentile growth
EA Score
52DFH 60DQ 39GM 55SS 45
v0.1 · 65/100 weight · provisional
↑ growth stability, return on assets · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$64.7M
Rev growth YoY (TTM)
+15.0%
Net income (FY)
-$11.4M
Employees
58
as of 2026-08-14
Market cap
$183.0M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$61.2M$61.2M2025
Net income-$11.4M-$11.4M2025
Operating income-$8.2M-$8.2M2025
Total assets$94.6M$94.6M2025
Liabilities$62.7M$62.7M2025
Equity$31.9M$31.9M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Qbrexza66%
Accutane34%
By geography
Not disclosed.
The read
What is Journey Medical Corporation’s revenue?
Journey Medical Corporation booked $61.2M in FY2025 revenue, growing 11% year over year — about the middle of the pack among Healthcare companies we track, at a -18.7% net margin.
Peers · Healthcare
DIH Holding US, Inc.——Sorrento Therapeutics, Inc.——Tango Therapeutics, Inc.55CFortress Biotech, Inc.62CKestra Medical Technologies, Ltd.——Etao International Co., Ltd.——Neighbors
Maricopa →Key facts
CEOClaude Maraoui
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersScottsdale, AZ
ExchangeNASDAQ: DERM
Employees58
IPO date2021-11-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.